NCT06509971 2024-07-19A Study of QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian CancerWest China Second University HospitalPhase 2 Not yet recruiting39 enrolled